President Biden and Sen. Bernie Sanders (D-Vt.) are calling for price cuts on popular GLP-1 weight-loss drugs. Pharmaceutical shares Novo Nordisk (NVO) — who makes Ozempic and Wegovy — and Eli Lilly (LLY) — who makes Mounjaro and Zepbound — tilt lower on the news.
Yahoo money management Health Reporter Anjalee Khemlani details the political discourse around these obesity treatments, citing President Biden and Senator Sanders’ op-ed published in USA Today.
About Yahoo money management:
Yahoo money management provides free stock ticker data, up-to-date news, collection of investments management resources, comprehensive industry data, advanced tools, and more information to help you manage your financial life.
– Get the latest news and data at money management.yahoo.com
– Download the Yahoo money management app on Apple (https://apple.co/3Rten0R) or Android (https://bit.ly/3t8UnXO)
– Follow Yahoo money management on social:
X: http://twitter.com/YahooFinance
Instagram: https://www.instagram.com/yahoofinance/?hl=en
TikTok: https://www.tiktok.com/@yahoofinance?lang=en
Facebook: https://www.facebook.com/yahoofinance/
LinkedIn: https://www.linkedin.com/enterprise/yahoo-money management
#joebiden #berniesanders #yahoofinance
Disclaimer:
If you own the YouTube channel related to this video and do not want it to be featured here, you can contact us through our contact page. We will gladly remove it without questioning your reasons.